Profile
POAI ISRG BDXA BDX RMD ALC
Company Name Predictive Oncology Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company ResMed Inc. Alcon Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $12.98M $157.06B $55.91B $54.60B $39.14B $36.21B
Employees 0.02K 15.64K 0.00K 70.00K 9.98K 25.60K
CEO Raymond F. Vennare Gary S. Guthart - Thomas E. Polen Jr. Michael J. Farrell BE, MBA, SM David J. Endicott
Ratings
POAI ISRG BDXA BDX RMD ALC
Quant Rating Score 2 3 5 3 4 3
Quant Rating Sell Neutral Strong Buy Neutral Buy Neutral
Trading
POAI ISRG BDXA BDX RMD ALC
Last Close $0.9503 $438.12 $59.24 $180.59 $267.31 $73.24
High 52 $1.95 $610.45 $59.24 $249.08 $293.73 $100.07
Low 52 $0.55 $433.48 $59.24 $165.15 $204.58 $73.24
Price vs. 52 Week High -51.27 % -28.23 % 0 % -27.5 % -8.99 % -26.81 %
Price vs. 52 Week Low 72.78 % 1.07 % 0 % 9.35 % 30.66 % 0 %
Total Return
POAI ISRG BDXA BDX RMD ALC
1 Month Return 6.78 % -7.6 % 0 % -6.95 % -6.32 % -10.08 %
3 Month Return 10.5 % -18 % 0 % 6.25 % 4.29 % -15.98 %
6 Month Return -40.61 % -13.93 % 0 % -20.79 % 20.48 % -19.8 %
9 Month Return 10.63 % -18.69 % 0 % -20.84 % 14.29 % -15.13 %
YTD Return 15.89 % -16.06 % 0 % -20.4 % 16.89 % -13.72 %
1 Year Return 25.44 % -9.91 % 0 % -23.89 % 10.2 % -26.08 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
POAI ISRG BDXA BDX RMD ALC
Dividend Yield Percentage (TTM) - - 2.24 % 2.18 % 0.82 % 0.46 %
Dividend Paid and Capex Coverage Ration (TTM) -2873709.33 % 3.4 % 1.73 % 1.73 % 4.34 % 3.26 %
Dividend Per Share (TTM) - - 4.16 % 4.16 % 2.19 % 0.33 %
Payout Ratio (TTM) - - 73.1 % 73.1 % 22.19 % 15.71 %
Growth
POAI ISRG BDXA BDX RMD ALC
Asset Growth -65.51 % 8.54 % 2.48 %
Gross Profit Growth -21.68 % 11.69 % 5.05 %
Revenue Growth -8.78 % 4.16 % 4.82 %
Revenue 3 Year -42.78 % 5.3 % 18.48 %
Revenue 5 Year -97.02 % 8.72 % 30.35 %
Revenue 10 Year - 59.37 % 50.3 %
EBIT Growth 21.42 % 19.82 % 41.82 %
Net Income Growth 12.75 % 14.89 % 4.52 %
Net Income 3 Yeari Growth Per Share 68.93 % -18.63 % 168.34 %
Net Income 5 Yeari Growth Per Share 98.37 % 28.82 % 253.24 %
Net Income 10 Yeari Growth Per Share - -4.02 % 239.64 %
Operating Income Growth 9.72 % 13.55 % 36 %
Operating Cash Flow Growth (CFG) 16.79 % 27.07 % 49.64 %
Operating 3 Year CFG 55 % -18.4 % 53.05 %
Operating 5 Year CFG 96.74 % 6.25 % 122.93 %
Operating 10 Year CFG - 45.28 % 55.79 %
EPS Growth 35.63 % 18.31 % 4.04 %
EPS Diluted Growth 35.63 % 18.62 % 4.59 %
Book Value Per Share -101.8 % -0.85 % 4.21 %
Share Holder 3 Year Equity Growth Per Share -100.25 % 9.16 % 10.93 %
Share Holder 5 Year Equity Growth Per Share -100.05 % 14.4 % 10.26 %
Share Holder 10 Year Equity Growth Per Share - 241.78 % -9.87 %
Dividend Per Share Growth - -2.44 % 11.75 %
Dividend 3 Year Growth Per Share - 4.79 % 138.09 %
Dividend 5 Year Growth Per Share - 4.14 % -
Dividend 10 Year Growth Per Share - 74.3 % -
Debt Growth -21.84 % 31.74 % 0.02 %
Free Cash Flow Growth 18.59 % 45.25 % 162.01 %
Updated On 31 Dec 2024 30 Sep 2024 31 Dec 2024
Profitability
POAI ISRG BDXA BDX RMD ALC
Gross Profit Margin TTM 32.62 % 66.65 % 45.08 % 45.08 % 59.36 % 55.13 %
Return on Assets TTM -284.62 % 12.93 % 2.93 % 2.93 % 17.14 % 3.42 %
Return on Equity TTM 112267.06 % 15.57 % 6.31 % 6.31 % 25.51 % 4.93 %
Return on Capital Employed TTM 2288.5 % 14.26 % 5.78 % 5.78 % 23.55 % 4.98 %
Net Income Per EBT TTM 113.05 % 87.46 % 83.91 % 83.91 % 83.5 % 85.57 %
EBT Per Ebit TTM 92.16 % 113.2 % 70.86 % 70.86 % 99.54 % 86.96 %
EBIT Per Revenue TTM -876.84 % 28.8 % 12.63 % 12.63 % 32.75 % 14.38 %
Cash Flow To Debt Ratio TTM -466.97 % - 16.82 % 16.82 % 198.52 % 39.27 %
Receivables Turnover TTM 46.62 6.56 7.27 7.27 5.48 4.98
Payables Turnover TTM 0.54 11.43 1.85 1.85 7.52 5.03
Inventory Turnover TTM 16.89 1.83 2.97 2.97 2.25 1.88
Fixed Asset Turnover TTM 51.93 % 183.44 % 313.67 % 313.67 % 716.47 % 197.54 %
Asset Turnover TTM 31.15 % 45.35 % 38.95 % 38.95 % 62.96 % 31.94 %
Operating Cash Flow Per Share TTM -0.95 7.88 11.3 11.3 11.96 4.16
Free Cash Flow Per Share TTM -0.95 5.56 8.85 8.85 11.32 3.23
Cash Per Share TTM 5.56 % 1485.77 % 262.85 % 262.85 % 825.72 % 284.33 %
Operating Cash Flow Sales Ratio TTM -805.51 % 30.9 % 15.22 % 15.22 % 34.04 % 20.57 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 70.57 % 78.37 % 78.37 % 94.7 % 77.51 %
Cash Flow Coverage Ratios TTM -466.97 % - 16.82 % 16.82 % 198.52 % 39.27 %
Price To Free Cash Flows Ratio TTM -1.51 78.75 20.91 21.41 23.6 22.65
Price To Operating Cash Flows Ratio TTM -1.25 55.58 16.47 16.86 22.35 17.59
Price Cash Flow Ratio TTM -1.25 55.58 16.47 16.86 22.35 17.59
Income Statement (TTM)
POAI ISRG BDXA BDX RMD ALC
Revenue $0B $8.35B $20.18B $20.18B $5.15B $9.91B
Gross Profit $0B $5.63B $9.13B $9.13B $3.05B $5.51B
Gross Profit Ratio 49.12% 67.46% 45.22% 45.22% 59.36% 55.61%
EBITDA $-0.01B $2.81B $4.82B $4.82B $1.91B $2.68B
Net Income $-0.01B $2.32B $1.71B $1.71B $1.4B $1.02B
EPS Diluted -2.24 6.42 5.86 5.86 9.51 2.05
Balance Sheet (MRQ)
POAI ISRG BDXA BDX RMD ALC
Long Term Debt $0B $0.11B $18.61B $18.61B $0.81B $4.97B
Total Liabilities $0.01B $2.31B $31.4B $31.4B $2.21B $8.79B
Total Equity $-0B $16.53B $25.89B $25.89B $5.97B $21.55B
Total Investments $0B $7.05B $0.45B $0.45B $0.1B $0.91B
Total Debt $0B $0.15B $20.92B $20.92B $0.88B $5.14B
Total Assets $0B $18.84B $57.29B $57.29B $8.17B $30.35B
Cash Flow Statement (TTM)
POAI ISRG BDXA BDX RMD ALC
Net Income $-0.01B $2.34B $1.71B $1.71B $1.4B $1.02B
Inventory $0B $-0.83B $0.1B $0.1B $-0.08B $-0.05B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.31B $-0.13B
Operating Cash Flow $-0.01B $2.42B $3.8B $3.8B $1.75B $2.08B
Capital Expenditure $-0B $-1.11B $-0.73B $-0.73B $-0.09B $-0.67B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 74.025
ANGO AngioDynamics, Inc. 10.68
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 131.84
ATRC AtriCure, Inc. 35.2401
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 28.62
BAX Baxter International Inc. 21.94
BDX Becton, Dickinson and Company 183.71
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 14.58
BLFS BioLife Solutions, Inc. 24.585
COO The Cooper Companies, Inc. 67.4658
DXR Daxor Corporation 12.1
EKSO Ekso Bionics Holdings, Inc. 5.157
FEMY Femasys Inc. 0.3527
ETFs With Exposure to POAI
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 326.905
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 144.71
VXF Vanguard Extended Market Index Fund 0.00005 208.895
DFAC Dimensional U.S. Core Equity 2 ETF 0.00000926 38.375
VTSAX Vanguard Total Stock Market Index Fund 0 158.25
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00005 157.29
VITSX Vanguard Total Stock Market Index Fund 0 158.28
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00005 157.3
VEMPX Vanguard Extended Market Index InstlPlus 0.00005 388.16
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 296.92
Unlock